SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-013728
Filing Date
2024-03-18
Accepted
2024-03-18 09:04:31
Documents
15
Period of Report
2024-03-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20024330_8k.htm   iXBRL 8-K 47369
2 EXHIBIT 3.1 ef20024330_ex3-1.htm EX-3.1 8885
3 EXHIBIT 3.2 ef20024330_ex3-2.htm EX-3.2 99206
  Complete submission text file 0001140361-24-013728.txt   325736

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krtx-20240314.xsd EX-101.SCH 3865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20240314_lab.xml EX-101.LAB 22691
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20240314_pre.xml EX-101.PRE 16552
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20024330_8k_htm.xml XML 4375
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 24757054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)